Documentation Centre

February 14, 2019
HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists? Lancet. 2018;392:1489-1490
Mafham M, Preiss D

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiovascular Disease, Clinical Trials, Diabetes